Effect of two treatment protocols upon pregnancy outcome in IVF

A Comparetive study of cyclogest and GNRH-A+ cyclogest effect on luteal phase support in cycles of frozen embryo transfer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017020510210N7

Enrollment

240

Registered

2017-03-01

Start date

2016-09-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility and treatment methods. Female infertility

Interventions

Intervention 1: Received cyclogest vaginal suppository twice a day for luteal phase support. Intervention 2: patients who received GNRH-A + Cyclogest.

Treatment - Drugs

Received cyclogest vaginal suppository twice a day for luteal phase support

patients who received GNRH-A + Cyclogest

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Un explain infertility,tubal factor,mild male factor,POF,PCO,age 20-40 y/o with normal uterine cavity Exclusion criteria: Age> 40y/o,abnormal uterine cavity, stage 3&4 endometriosis,hydrosalpinx,sever male factor,unsuccess embryo transfer>2 cycle

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate. Timepoint: 6 week gestation. Method of measurement: Vaginal sonogeraphy trans.	—

Secondary

Measure	Time frame
Ongoing pregnancy rate,Abortion rate. Timepoint: 12 week gestation. Method of measurement: Trans vaginal sonogeraphy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marazieh Eslamimoghadam

Shiraz University of Medical Sciences

marzieh.eslami@ymail.comhafez_perina@sums.ac.ir+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026